- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/64 - Cyclic peptides containing only normal peptide links
Patent holdings for IPC class C07K 7/64
Total number of patents in this class: 1889
10-year publication summary
|
134
|
137
|
121
|
135
|
129
|
139
|
127
|
147
|
165
|
135
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Entrada Therapeutics, Inc. | 87 |
42 |
| Polyphor AG | 72 |
40 |
| Ohio State Innovation Foundation | 2406 |
36 |
| Chugai Seiyaku Kabushiki Kaisha | 1426 |
35 |
| Endevica bio, Inc. | 66 |
35 |
| The University of British Columbia | 1554 |
31 |
| Bicyclerd Limited | 151 |
31 |
| Merck Sharp & Dohme LLC | 3733 |
27 |
| The Regents of the University of California | 20902 |
26 |
| Allergan, Inc. | 2148 |
24 |
| Protagonist Therapeutics, Inc. | 154 |
22 |
| Peptidream Inc. | 106 |
19 |
| The University of Tokyo | 4390 |
19 |
| Heidelberg Pharma Research GmbH | 83 |
19 |
| Centre National de La Recherche Scientifique | 11111 |
16 |
| University of Southern California | 2146 |
16 |
| Farsight Medical Technology (Shanghai) Co., Ltd. | 26 |
16 |
| Apellis Pharmaceuticals, Inc. | 135 |
15 |
| Novartis AG | 10169 |
14 |
| Bausch Health Ireland Limited | 801 |
14 |
| Other owners | 1392 |